New Zealand markets close in 5 hours 7 minutes

Lixte Biotechnology Holdings, Inc. (LIXT)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.8821+0.0021 (+0.07%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
898.1
898.1
1,349
1,737
1,224
Selling general and administrative
4,192
4,192
4,962
4,984
2,043
Total operating expenses
5,090
5,090
6,311
6,720
3,266
Operating income or loss
-5,090
-5,090
-6,311
-6,720
-3,266
Interest expense
16.233
16.233
8.875
7.414
3.674
Total other income/expenses net
1.954
1.954
-3.374
-1.163
0.89
Income before tax
-5,087
-5,087
-6,313
-6,728
-3,265
Income from continuing operations
-5,087
-5,087
-6,313
-6,728
-3,265
Net income
-5,087
-5,087
-6,313
-6,728
-3,265
Net income available to common shareholders
-5,087
-5,087
-6,313
-6,728
-3,265
Basic EPS
-3.24
-2.66
-3.99
-5.00
-2.90
Diluted EPS
-3.24
-2.66
-3.99
-5.00
-2.90
Basic average shares
1,769
1,916
1,582
1,347
1,128
Diluted average shares
1,769
1,916
1,582
1,347
1,128